Insider Transactions in Q3 2021 at Arvinas, Inc. (ARVN)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 07
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
36,411
-0.54%
|
$3,240,579
$89.43 P/Share
|
|
Sep 03
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
32,387
-0.94%
|
$2,752,895
$85.93 P/Share
|
|
Sep 02
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
51,765
-1.47%
|
$4,400,025
$85.88 P/Share
|
|
Sep 02
2021
|
John G Houston President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,690
+0.28%
|
$75,040
$16.0 P/Share
|
|
Sep 01
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
79,437
-1.09%
|
$6,911,019
$87.23 P/Share
|
|
Aug 31
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
59,355
-1.56%
|
$5,045,175
$85.8 P/Share
|
|
Aug 30
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
58,838
-0.75%
|
$5,060,068
$86.83 P/Share
|
|
Aug 27
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
45,026
-1.12%
|
$3,827,210
$85.72 P/Share
|
|
Aug 26
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
11,712
-0.58%
|
$995,520
$85.12 P/Share
|
|
Aug 26
2021
|
Bradley Albert Margus Director |
SELL
Open market or private sale
|
Indirect |
9,940
-83.25%
|
$844,900
$85.03 P/Share
|
|
Aug 25
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
14,267
-0.7%
|
$1,212,695
$85.03 P/Share
|
|
Aug 25
2021
|
Bradley Albert Margus Director |
SELL
Open market or private sale
|
Indirect |
20,000
-62.62%
|
$1,700,000
$85.0 P/Share
|
|
Aug 24
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
9,203
-0.22%
|
$800,661
$87.01 P/Share
|
|
Aug 23
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
1,599
-0.08%
|
$140,712
$88.01 P/Share
|
|
Aug 16
2021
|
Ian Taylor Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,000
-7.15%
|
$1,740,000
$87.6 P/Share
|
|
Aug 16
2021
|
Ian Taylor Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+16.86%
|
$320,000
$16.0 P/Share
|
|
Aug 13
2021
|
Bradley Albert Margus Director |
SELL
Open market or private sale
|
Indirect |
5,828
-15.43%
|
$524,520
$90.03 P/Share
|
|
Aug 12
2021
|
Ronald Peck Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,363
-20.15%
|
$122,670
$90.54 P/Share
|
|
Aug 12
2021
|
Ronald Peck Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,011
+37.22%
|
-
|
|
Aug 11
2021
|
Bradley Albert Margus Director |
SELL
Open market or private sale
|
Indirect |
5,000
-11.69%
|
$450,000
$90.03 P/Share
|
|
Aug 02
2021
|
John G Houston President and CEO |
SELL
Open market or private sale
|
Direct |
45,922
-1.07%
|
$4,500,356
$98.82 P/Share
|
|
Aug 02
2021
|
John G Houston President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
45,922
+4.99%
|
$734,752
$16.0 P/Share
|
|
Jul 28
2021
|
Sean A Cassidy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,242
-9.83%
|
$1,724,200
$100.0 P/Share
|
|
Jul 28
2021
|
Sean A Cassidy Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,242
+8.95%
|
$275,872
$16.0 P/Share
|